Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
T

Tabula Rasa HealthCare Inc
F:43T

Watchlist Manager
Tabula Rasa HealthCare Inc
F:43T
Watchlist
Price: 9.6 EUR Market Closed
Market Cap: €260.4m
Write Note Create Alert Ask AI

Relative Value

There is not enough data to reliably calculate the relative value of 43T.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

43T Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

P/S
View Details
P/E
View Details
P/OCF
View Details
P/FCFE
View Details
P/B
View Details
EV/S
View Details
EV/GP
View Details
EV/EBITDA
View Details
EV/EBIT
View Details
EV/OCF
View Details
EV/FCFF
View Details
EV/IC
View Details

Multiples Across Competitors

43T Competitors Multiples
Tabula Rasa HealthCare Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Tabula Rasa HealthCare Inc
F:43T
259.8m EUR 0.9 -3.2 -21 -11
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
US
Veeva Systems Inc
NYSE:VEEV
30.2B USD 9.8 35.1 25.3 26.5
AU
Pro Medicus Ltd
ASX:PME
16.5B AUD 76.1 145.6 100.3 100.3
JP
M3 Inc
TSE:2413
1.2T JPY 3.4 23.8 11.8 14.3
US
Doximity Inc
NYSE:DOCS
5.2B USD 8.4 20.6 16.8 17.6
SE
Sectra AB
STO:SECT B
40.1B SEK 17.9 62 -122.1 -122.1
US
Waystar Holding Corp
NASDAQ:WAY
4.2B USD 4.1 37.9 13.1 20.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
24.5B CNY 10.9 -76.6 -151.4 -151.4
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
288.2B INR 10.9 59.6 36.6 42.7
US
Vocera Communications Inc
F:V00
2.4B EUR 11.9 -328 267.9 4 290.1
P/E Multiple
Earnings Growth PEG
US
T
Tabula Rasa HealthCare Inc
F:43T
Average P/E: 54.7
Negative Multiple: -3.2 		N/A N/A
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
35.1
32%
1.1
AU
Pro Medicus Ltd
ASX:PME
145.6
32%
4.6
JP
M3 Inc
TSE:2413
23.8
16%
1.5
US
Doximity Inc
NYSE:DOCS
20.6
18%
1.1
SE
Sectra AB
STO:SECT B
62
17%
3.6
US
W
Waystar Holding Corp
NASDAQ:WAY
37.9
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -76.6
69%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
59.6
31%
1.9
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
T
Tabula Rasa HealthCare Inc
F:43T
Average EV/EBITDA: 61.7
Negative Multiple: -21 		N/A N/A
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
25.3
38%
0.7
AU
Pro Medicus Ltd
ASX:PME
100.3
32%
3.1
JP
M3 Inc
TSE:2413
11.8
14%
0.8
US
Doximity Inc
NYSE:DOCS
16.8
23%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -122.1 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
13.1
24%
0.5
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -151.4
36%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
36.6
24%
1.5
US
V
Vocera Communications Inc
F:V00
267.9
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
T
Tabula Rasa HealthCare Inc
F:43T
Average EV/EBIT: 569.4
Negative Multiple: -11 		N/A N/A
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
26.5
39%
0.7
AU
Pro Medicus Ltd
ASX:PME
100.3
31%
3.2
JP
M3 Inc
TSE:2413
14.3
N/A N/A
US
Doximity Inc
NYSE:DOCS
17.6
25%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -122.1 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
20.6
58%
0.4
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -151.4
47%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
42.7
26%
1.6
US
V
Vocera Communications Inc
F:V00
4 290.1
N/A N/A

See Also

Summary
43T intrinsic value, competitors valuation, and company profile.
DCF Valuation
43T stock valuation using Discount Cash Flow valuation method.
Relative Valuation
43T stock valuation using valuation multiples.
Wall Street Estimates
43T price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
43T stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 316,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.